Details of Viral Vaccine
This Viral vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 10350 |
| Vaccine Name | Skycovion |
| Disease Name | COVID-19 |
| Disease Classification | Respiratory |
| Virus Name | SARS-CoV-2 virus |
| Nucleic Acid Content | positive-sense, single-stranded RNA |
| Vaccine Type | Protein subunit |
| Vaccine Status | Phase 3 |
| Manufacturer | SK Bioscience Co. Ltd. |
| Year of Manufacturing | 2021 |
| Manufacturing Country | South Korea |
| Age | 19 - 85 years |
| Dosage | 2 doses 28 days apart |
| Administration Route | Intramuscular |
| Adjuvant | AS03 |
| Target Strain | Recombinant SARS-CoV-2 protein |
| Description | NA |
| Approving Organisation | NA |
| Collaborating Organisation | International Vaccine Institute, GlaxoSmithKline, Coalition for Epidemic Preparedness Innovations |
| Other Countries | NA |
| Trade Name | GBP510 |
| PMID | NA |
| Clinical Trial ID | NCT04750343 |
| Reference Link | https://clinicaltrials.gov/show/NCT04750343 |
| Additional Links | NA |